Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milos D Miljkovic

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Oncology Practice|December 12, 2019
Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for OncologistsMarc Sorigue, Milos D Miljkovic
Blood Reviews|November 14, 2020
Systematic review of staging bone marrow involvement in B cell lymphoma by flow cytometryMarc Sorigue, Eloi Cañamero, Milos D Miljkovic
The Journal of Experimental Medicine|December 11, 2019
Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancerThomas A Waldmann, Milos D Miljkovic, Kevin C Conlon
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 12, 2018
Cytokines in the Treatment of CancerKevin C Conlon, Milos D Miljkovic, Thomas A Waldmann
Frontiers in Immunology|June 9, 2020
IL-15 in the Combination Immunotherapy of CancerThomas A Waldmann, Sigrid Dubois, Milos D Miljkovic, et al.
Blood Advances|April 27, 2022
Interleukin-15 augments NK cell-mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignanciesMilos D Miljkovic, Sigrid P Dubois, Jürgen R Müller, et al.
Cytometry. Part B, Clinical Cytometry|November 7, 2019
Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemiaMarc Sorigue, Laura Magnano, Milos D Miljkovic, et al.
Blood Advances|August 25, 2021
Next-generation sequencing-based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCLMilos D Miljkovic, Christopher Melani, Stefania Pittaluga, et al.
Translational Oncology|October 31, 2020
Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemiaAnusara Daenthanasanmak, Yuquan Lin, Meili Zhang, et al.
Blood Neoplasia|June 23, 2025
A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignanciesMax J Gordon, Sigrid Dubois, Milos D Miljkovic, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Oncology Practice|December 12, 2019
Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for OncologistsMarc Sorigue, Milos D Miljkovic
Blood Reviews|November 14, 2020
Systematic review of staging bone marrow involvement in B cell lymphoma by flow cytometryMarc Sorigue, Eloi Cañamero, Milos D Miljkovic
The Journal of Experimental Medicine|December 11, 2019
Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancerThomas A Waldmann, Milos D Miljkovic, Kevin C Conlon
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 12, 2018
Cytokines in the Treatment of CancerKevin C Conlon, Milos D Miljkovic, Thomas A Waldmann
Frontiers in Immunology|June 9, 2020
IL-15 in the Combination Immunotherapy of CancerThomas A Waldmann, Sigrid Dubois, Milos D Miljkovic, et al.
Blood Advances|April 27, 2022
Interleukin-15 augments NK cell-mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignanciesMilos D Miljkovic, Sigrid P Dubois, Jürgen R Müller, et al.
Cytometry. Part B, Clinical Cytometry|November 7, 2019
Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemiaMarc Sorigue, Laura Magnano, Milos D Miljkovic, et al.
Blood Advances|August 25, 2021
Next-generation sequencing-based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCLMilos D Miljkovic, Christopher Melani, Stefania Pittaluga, et al.
Translational Oncology|October 31, 2020
Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemiaAnusara Daenthanasanmak, Yuquan Lin, Meili Zhang, et al.
Blood Neoplasia|June 23, 2025
A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignanciesMax J Gordon, Sigrid Dubois, Milos D Miljkovic, et al.
Pageof 2